You are here

  • Home
  • Archive
  • Volume 11, Issue 2
  • Suitability of tumor-associated antibodies as predictive biomarker for response to immune checkpoint inhibitors in patients with melanoma: a short report

Article metrics

Article menu
Immunotherapy biomarkers
Suitability of tumor-associated antibodies as predictive biomarker for response to immune checkpoint inhibitors in patients with melanoma: a short report

 

Online download statistics by month:

Online download statistics by month: February 2023 to February 2026

AbstractFullPdf
Feb 2023434439141
Mar 202312212343
Apr 202310310538
May 2023737333
Jun 2023626216
Jul 2023636422
Aug 202393939
Sep 2023595916
Oct 2023555625
Nov 2023666618
Dec 2023565724
Jan 2024424219
Feb 2024333318
Mar 2024404033
Apr 2024474732
May 2024272713
Jun 2024373612
Jul 2024404120
Aug 2024222110
Sep 2024252515
Oct 2024323218
Nov 202417197
Dec 2024313215
Jan 2025212219
Feb 202552527
Mar 2025222222
Apr 2025676829
May 2025303036
Jun 2025212212
Jul 2025110
Dec 2025110
Feb 2026110
Total17951811722